Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin I (PRDX1) is an abundant, highly conserved cysteine-dependent peroxidase enzyme and key member of the peroxiredoxin family. It reduces hydrogen peroxide, organic hydroperoxides, and peroxynitrite to protect cells from oxidative damage and regulate redox balance. PRDX1 is involved in cell signaling, especially in modulating peroxide-mediated signal transduction, and plays roles in cell differentiation, proliferation, and stress response. Dysregulation or altered expression of PRDX1 has important implications in cancer biology, inflammation, cardiovascular and neurodegenerative diseases. In addition to classical peroxidase activity, PRDX1 can function as a disulfide reductase, influencing processes such as motor neuron differentiation through interaction with proteins like GDE2.
Reduction of peroxides and ROS (reactive oxygen species) via cysteine-dependent mechanisms. Regulatory modulation of cell signaling by oxidation state transfer to effector proteins. Disulfide reductase activity for other protein targets (e.g. GDE2).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin I (PRDX1).